The forecast for musculo-skeletal system medicine sales in Canada indicates a modest decline from 2024 to 2028, starting at 3% of total sales in 2024, and sustaining at 2.9% in subsequent years. This is a slight shift that reflects a stabilization after the initial decrease from the prior year.

Key trends to monitor include:

Potential innovations in treatment options that may shift market dynamics.
Continued impact of healthcare regulations and reimbursement policies on sales.
Demographic changes, such as an aging population, which could influence demand for musculo-skeletal medications.